Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Determining appropriate levels of care for treatment of substance use disorders

Karen Hartwell, MD
Kathleen Brady, MD, PhD
Section Editor
Richard Saitz, MD, MPH, FACP, DFASAM
Deputy Editor
Richard Hermann, MD


Patients with chronic or relapsing substance use disorders (SUD) make up 40 to 60 percent of individuals who receive SUD care [1-3]. These patients typically have marked impairments in functioning and high rates of co-occurring medical, mental health, and social problems that need to be addressed.

With increasing recognition of the substantial patient population with a chronic SUD (addiction), the SUD-treatment model is shifting from episodic to continuing care, based on the chronic care model [4]. In managing patients with chronic SUDs, the patient’s clinical status and risk of relapse are monitored systematically and longitudinally. As the patient’s addiction waxes and wanes over time (ie, experiences periods of abstinence, relapse, or fluctuations in risk of relapse), the intensiveness and types of treatment are adjusted.

This topic describes the continuum of care for SUDs, and factors that influence the determination of patients’ level of care. Other aspects of continuing care for SUDs (ie, indications, features, efficacy, and implementation) are described separately. Treatment for individual SUDs are also described separately.

(See "Continuing care for addiction: Indications, features, and efficacy".)

(See "Continuing care for addiction: Implementation".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jun 16, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Finney JW, Moos RH. The long-term course of treated alcoholism: II. Predictors and correlates of 10-year functioning and mortality. J Stud Alcohol 1992; 53:142.
  2. Hubbard RL, Craddock G, Flynn PM, et al. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:261.
  3. McLellan AT, McKay J. The treatment of addiction: what can research offer practice? In: Bridging the Gap: Forging New Partnerships in Community-Based Drug Abuse Treatment, Lamb S, Greenlick M, McCarty D (Eds), National Academy Press, Washington, DC 1998.
  4. Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract 2007; 4:45.
  5. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, 3rd ed., Mee-Lee D, Shulman GD, Fishman MJ, et al. (Eds), The Change Company, Carson City, NV 2013.
  6. Jason LA, Olson BD, Ferrari JR, et al. An examination of main and interactive effects of substance abuse recovery housing on multiple indicators of adjustment. Addiction 2007; 102:1114.
  7. Moos RH, Pettit B, Gruber VA. Characteristics and outcomes of three models of community residential care for abuse patients. J Subst Abuse 1995; 7:99.
  8. Moos RH, Moos BS. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders. Psychiatr Serv 1995; 46:66.
  9. Moos RH, King MJ. Participation in community residential treatment and substance abuse patients' outcomes at discharge. J Subst Abuse Treat 1997; 14:71.
  10. Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv 1999; 50:1577.
  11. De Leon G. Therapeutic communities for addictions: a theoretical framework. Int J Addict 1995; 30:1603.
  12. Hayahida, M, Alterman, AI, McLellan, AT, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-moderate alcohol withdrawal syndrome. N Eng J Med 1989; 320:358.
  13. Pearson FS, Prendergast ML, Podus D, et al. Meta-analyses of seven of the National Institute on Drug Abuse's principles of drug addiction treatment. J Subst Abuse Treat 2012; 43:1.
  14. Magura S, Staines G, Kosanke N, et al. Predictive validity of the ASAM Patient Placement Criteria for naturalistically matched vs. mismatched alcoholism patients. Am J Addict 2003; 12:386.
  15. Sharon E, Krebs C, Turner W, et al. Predictive validity of the ASAM Patient Placement Criteria for hospital utilization. J Addict Dis 2003; 22 Suppl 1:79.
  16. Chen S, Barnett PG, Sempel JM, Timko C. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity. J Subst Abuse Treat 2006; 31:95.
  17. Merkx MJ, Schippers GM, Koeter MW, et al. Guidelines for allocating outpatient alcohol abusers to levels of care: Predictive validity. Addict Behav 2011; 36:570.
  18. Merkx MJ, Schippers GM, Koeter MW, et al. Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients. Addict Behav 2013; 38:1691.
  19. McKay JR, Cacciola JS, McLellan AT, et al. An initial evaluation of the psychosocial dimensions of the American Society of Addiction Medicine criteria for inpatient versus intensive outpatient substance abuse rehabilitation. J Stud Alcohol 1997; 58:239.
  20. American Society of Addiction Medicine. ASAM PPC-2R- ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, 2nd ed, rev, American Society of Addiction Medicine, Chevy Chase, MD 2001.
  21. Haug NA, Duffy M, McCaul ME. Substance abuse treatment services for pregnant women: psychosocial and behavioral approaches. Obstet Gynecol Clin North Am 2014; 41:267.
  22. Westermeyer J, Lee K. Residential placement for veterans with addiction: American Society of Addiction Medicine criteria vs. a veterans homeless program. J Nerv Ment Dis 2013; 201:567.
  23. Melnick G, De Leon G, Thomas G, Kressel D. A client-treatment matching protocol for therapeutic communities: first report. J Subst Abuse Treat 2001; 21:119.
  24. Stallvik M, Gastfriend DR, Nordahl HM. Matching patients with substance use disorders to optimal level of care with ASAM criteria software. J Subst Use 2014.
  25. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002; 59:115.
  26. Cornelius JR, Reynolds M, Martz BM, et al. Premature mortality among males with substance use disorders. Addict Behav 2008; 33:156.
  27. Lambert-Harris C, Saunders EC, McGovern MP, Xie H. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care. J Addict Med 2013; 7:25.